South San Francisco, Calif., firm Exelixis has added two new executives: Michael Morrissey, vice-president, discovery research, and Michael Rusnak, vice-president, pharmaceutical business development. Morrissey was previously with Berlex Biosciences and Rusnak had been an executive with CombiChem.